Brief: Cerevel Therapeutics Holdings Says Under Deal, Co May Be Required To Pay Abbvie A Termination Fee Of Approximately $283.1 Mln

Cerevel Therapeutics Holdings

07/12/2023 13:25

Dec 7 (Reuters) - Abbvie Inc  ABBV.N :
    * CEREVEL THERAPEUTICS HOLDINGS INC- UNDER DEAL, CO MAY BE
REQUIRED TO PAY ABBVIE A TERMINATION FEE OF APPROXIMATELY $283.1
MILLION
    * CEREVEL THERAPEUTICS HOLDINGS INC- UNDER CERTAIN
CONDITIONS
ABBVIE MAY BE REQUIRED TO PAY CO A TERMINATION FEE OF
APPROXIMATELY $653.3 MILLION

Further company coverage:  ABBV.N 

 ((reuters.briefs@thomsonreuters.com;))